"Castleman Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.
| Descriptor ID |
D005871
|
| MeSH Number(s) |
C15.604.515.245 C20.683.515.250
|
| Concept/Terms |
Castleman Disease- Castleman Disease
- Angiofollicular Lymphoid Hyperplasia
- Angiofollicular Lymphoid Hyperplasias
- Hyperplasia, Angiofollicular Lymphoid
- Lymphoid Hyperplasia, Angiofollicular
- Castleman's Disease
- Angiofollicular Lymph Node Hyperplasia
- Hyperplasia, Giant Lymph Node
- Lymph Node Hyperplasia, Giant
- Angiofollicular Lymph Hyperplasia
- Angiofollicular Lymph Hyperplasias
- Hyperplasia, Angiofollicular Lymph
- Lymph Hyperplasia, Angiofollicular
- Castlemans Disease
- Disease, Castlemans
- Giant Lymph Node Hyperplasia
- Castleman's Tumor
- Castleman Tumor
- Castlemans Tumor
- Tumor, Castleman's
|
Below are MeSH descriptors whose meaning is more general than "Castleman Disease".
Below are MeSH descriptors whose meaning is more specific than "Castleman Disease".
This graph shows the total number of publications written about "Castleman Disease" by people in this website by year, and whether "Castleman Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Castleman Disease" by people in Profiles.
-
Newman SK, Jayanthan RK, Mitchell GW, Carreras Tartak JA, Croglio MP, Suarez A, Liu AY, Razzo BM, Oyeniran E, Ruth JR, Fajgenbaum DC. Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research. Yale J Biol Med. 2015 Dec; 88(4):383-8.
-
Williams AD, Sanchez A, Hou JS, Rubin RR, Hysell ME, Babcock BD, Shaikh MF, Weingarten MS, Bowne WB. Retroperitoneal Castleman's disease: advocating a multidisciplinary approach for a rare clinical entity. World J Surg Oncol. 2014 Feb 04; 12:30.
-
Grier JT, Forbes LR, Monaco-Shawver L, Oshinsky J, Atkinson TP, Moody C, Pandey R, Campbell KS, Orange JS. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J Clin Invest. 2012 Oct; 122(10):3769-80.
-
Liu DT, Shields JA, Li CL, Ng HK, Lam DS. Hypertensive choroidopathy in Castleman's disease. Graefes Arch Clin Exp Ophthalmol. 2011 Dec; 249(12):1901-3.
-
Bandera B, Ainsworth C, Shikle J, Rupard E, Roach M. Treatment of unicentric Castleman disease with neoadjuvant rituximab. Chest. 2010 Nov; 138(5):1239-41.
-
Wang H, Wieczorek RL, Zenilman ME, Desoto-Lapaix F, Ghosh BC, Bowne WB. Castleman's disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome. World J Surg Oncol. 2007 Nov 20; 5:133.
-
Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer. 1999 Feb 01; 85(3):706-17.
-
Miettinen M, Lasota J. Polymerase chain reaction based gene rearrangement studies in the diagnosis of follicular lymphoma--performance in formaldehyde-fixed tissue and application in clinical problem cases. Pathol Res Pract. 1997; 193(1):9-19.
-
Glazer M, Rao VM, Reiter D, McCue P. Isolated Castleman disease of the neck: MR findings. AJNR Am J Neuroradiol. 1995 Apr; 16(4):669-71.